Literature DB >> 16120401

Biochemical examination of fibroblasts in the diagnosis and research of oxidative phosphorylation (OXPHOS) defects.

L P van den Heuvel1, J A Smeitink, R J T Rodenburg.   

Abstract

The oxidative phosphorylation system (OXPHOS) is organized in five multi-protein complexes, comprising four complexes (I-IV) of the respiratory chain and ATP synthase (complex V). OXPHOS has a vital role in cellular energy metabolism and ATP production. Enzyme analysis of individual OXPHOS complexes in a skeletal muscle biopsy remains the mainstay of the diagnostic process for patients suspected of mitochondrial cytopathy. A fresh muscle biopsy is preferable to a frozen muscle biopsy because of the possibility to measure the overall capacity of the OXPHOS system. In about 25% of patients referred to our center for muscle biopsy, reduced substrate oxidation rates and ATP + creatine phosphate production rates were found without any defect in complex I-V and the pyruvate dehydrogenase complex. In a subset of patients it is necessary to investigate fibroblasts for diagnostic purposes. The indications for biochemical investigations in fibroblasts are: (a) If no muscle sample is available; (b) If prenatal diagnosis is required; (c) To clarify the results obtained in muscle tissue if no clear-cut diagnosis can be made; (d) If molecular-genetic investigations are required; (e) For research purposes. Fibroblasts are less suitable than fresh muscle for investigating respiratory chain disorders, for the following reasons: (i) A defect that is present in a muscle is not always expressed in fibroblasts. (ii) Exclusion of a defect in fibroblasts does not exclude the diagnosis with regard to muscle. (iii) A specific pattern of abnormalities demonstrated in fibroblasts may not be reflected in muscle tissue. (iv) Enzyme deficiencies found in muscle are generally more pronounced than in fibroblasts. An exact diagnosis of respiratory chain defects is a prerequisite for rational therapy and genetic counseling. Provided guidelines for specimen collection are followed, there are now reliable methods for identifying respiratory chain defects.

Entities:  

Year:  2004        PMID: 16120401     DOI: 10.1016/j.mito.2004.07.005

Source DB:  PubMed          Journal:  Mitochondrion        ISSN: 1567-7249            Impact factor:   4.160


  12 in total

1.  Sequence analysis of nuclear genes encoding functionally important complex I subunits in children with encephalomyopathy.

Authors:  Reetta Hinttala; Johanna Uusimaa; Anne M Remes; Heikki Rantala; Ilmo E Hassinen; Kari Majamaa
Journal:  J Mol Med (Berl)       Date:  2005-09-03       Impact factor: 4.599

Review 2.  Biochemical diagnosis of mitochondrial disorders.

Authors:  Richard J T Rodenburg
Journal:  J Inherit Metab Dis       Date:  2010-05-04       Impact factor: 4.982

Review 3.  The in-depth evaluation of suspected mitochondrial disease.

Authors:  Richard H Haas; Sumit Parikh; Marni J Falk; Russell P Saneto; Nicole I Wolf; Niklas Darin; Lee-Jun Wong; Bruce H Cohen; Robert K Naviaux
Journal:  Mol Genet Metab       Date:  2008-02-01       Impact factor: 4.797

Review 4.  Diagnosis and treatment of mitochondrial myopathies.

Authors:  Gerald Pfeffer; Patrick F Chinnery
Journal:  Ann Med       Date:  2011-08-25       Impact factor: 4.709

5.  A multi-center comparison of diagnostic methods for the biochemical evaluation of suspected mitochondrial disorders.

Authors:  R J T Rodenburg; G C Schoonderwoerd; V Tiranti; R W Taylor; A Rötig; L Valente; F Invernizzi; D Chretien; L He; G P B M Backx; K J G M Janssen; P F Chinnery; H J Smeets; I F de Coo; L P van den Heuvel
Journal:  Mitochondrion       Date:  2012-11-17       Impact factor: 4.160

Review 6.  Mitochondrial dysfunctions in neurodegenerative diseases: relevance to Alzheimer's disease.

Authors:  Jana Hroudová; Namrata Singh; Zdeněk Fišar
Journal:  Biomed Res Int       Date:  2014-05-12       Impact factor: 3.411

Review 7.  Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society.

Authors:  Sumit Parikh; Amy Goldstein; Mary Kay Koenig; Fernando Scaglia; Gregory M Enns; Russell Saneto; Irina Anselm; Bruce H Cohen; Marni J Falk; Carol Greene; Andrea L Gropman; Richard Haas; Michio Hirano; Phil Morgan; Katherine Sims; Mark Tarnopolsky; Johan L K Van Hove; Lynne Wolfe; Salvatore DiMauro
Journal:  Genet Med       Date:  2014-12-11       Impact factor: 8.822

8.  Mitochondrial mosaics in the liver of 3 infants with mtDNA defects.

Authors:  Frank Roels; Patrick Verloo; François Eyskens; Baudouin François; Sara Seneca; Boel De Paepe; Jean-Jacques Martin; Valerie Meersschaut; Marleen Praet; Emmanuel Scalais; Marc Espeel; Joél Smet; Gert Van Goethem; Rudy Van Coster
Journal:  BMC Clin Pathol       Date:  2009-06-05

9.  QIL1 mutation causes MICOS disassembly and early onset fatal mitochondrial encephalopathy with liver disease.

Authors:  Virginia Guarani; Claude Jardel; Dominique Chrétien; Anne Lombès; Paule Bénit; Clémence Labasse; Emmanuelle Lacène; Agnès Bourillon; Apolline Imbard; Jean-François Benoist; Imen Dorboz; Mylène Gilleron; Eric S Goetzman; Pauline Gaignard; Abdelhamid Slama; Monique Elmaleh-Bergès; Norma B Romero; Pierre Rustin; Hélène Ogier de Baulny; Joao A Paulo; J Wade Harper; Manuel Schiff
Journal:  Elife       Date:  2016-09-13       Impact factor: 8.140

Review 10.  Myopathology of Adult and Paediatric Mitochondrial Diseases.

Authors:  Rahul Phadke
Journal:  J Clin Med       Date:  2017-07-04       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.